Guggenhime Andrew

PRESIDENT AND CFOVaxcyte, Inc. (PCVX) · full profile →Form 4 · filed Aug 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$539K
Net Open-Market Flow
-$539K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 3, 2026Option exercise(M)10K$5.35$54K115K
Aug 3, 2026Sell(S)7K$53.76$374K108K
Aug 3, 2026Sell(S)3K$54.18$165K105K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 3, 2026Option exercise(M)10K$0217K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001230724-26-000014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.